Estudo comparativo entre o tecido ósseo criopreservado e o conservado em glicerol a 98% by Giovani, Arlete Mazzini Miranda et al.
565
CLINICS 2006;61(6):565-70
Tissue Bank, Institute of Orthopedics and Traumatology, Hospital das
Clínicas, São Paulo University Medical School - São Paulo/SP, Brazil.
Email: giovani@inin.com.br
Received for publication on July 21, 2006.
Accepted for publication on August 29, 2006.
BASIC RESEARCH
COMPARATIVE STUDY OF CRYOPRESERVED BONE
TISSUE AND TISSUE PRESERVED IN A 98%
GLYCEROL SOLUTION
Arlete Mazzini Miranda Giovani, Alberto Tesconi Croci, Cláudia Regina GCM
Oliveira, Renée Zon Filippi, Luiz Augusto U. Santos, Graziela G Maragni, Thays
Moreira Albhy
Giovani AMM, Croci AT, Oliveira CRGCM, Filippi RZ, Santos LAU, Maragni GG. Comparative study of cryopreserved
bone tissue and tissue preserved in a 98% glycerol solution. Clinics. 2006;61(6):565-70.
OBJECTIVE: To compare the bone graft cryopreservation method (at -80ºC) with a preservation method using a 98% glycerol
solution at room temperature (10ºC-35ºC), by testing the antibacterial and fungal effects of 98% glycerol and comparatively
analyzing the observed histological changes resulting from the use of both methods.
METHOD: This study was of 30 samples of trabecular bone tissue from 10 patients undergoing total hip arthroplasty. Each
femoral head provided 3 samples that were randomized into 3 groups, namely, the control group, the cryopreserved group, and the
group preserved in a 98% glycerol at room temperature for 1 year. The samples were submitted to histomorphologic, cell feasibility,
and microbiologic analyses. The results were statistically analyzed using the McNemar test, with a statistical significance index
of 0.05.
RESULTS: Values obtained using the McNemar test to compare probability distributions of histomorphologic variables (mature
or lamellar bone, immature bone, and necrosis) and cell feasibility (osteoblasts and osteoclasts) indicated that there is no difference
between the distributions of variables under the 3 experimental conditions. Microbiological analysis of the 98% glycerol solution
and bone fragments from samples stored for 1 year at room temperature did not show bacterial or fungal growth. The histological
and microbiological investigation were performed at 2 different time points: immediately after the sample processing and after 1
year.
CONCLUSION: The method used to preserve bone grafts kept in 98% glycerol at room temperature (10ºC-35ºC) was similar to
cryopreservation in terms of bone matrix preservation; no bacteria or fungi were found in the samples.
KEYWORDS: Bone tissue. Glycerol. Bone transplant. Cryopreservation. Bone graft.
INTRODUCTION
The need to use allografts intended to surgically fill
bone losses is quite old. Autologous grafts are often used
to repair injured structures, although it is not always pos-
sible to obtain them in the desired quantity and quality. For
this reason, homologous grafts appeared as an alternative
to enrich the therapeutic arsenal, replacing the autologous
grafts in the treatment of many orthopedic affections re-
quiring replacement of large amounts of bone tissue.1-5
Allograft storage is but one stage to be controlled within
the entire process that culminates with the provision of the
graft for transplant. For each stage, technical and quality
criteria have been established within the methodology cur-
rently required for the musculoskeletal system tissue bank
to work, and such criteria were strictly met.
Freezing is currently the method of choice for allograft
preservation, since it reduces the immunogenic potential
while preserving the biomechanical and osteoinductive
properties. In addition to inhibiting bacterial growth, fro-
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zen speciments maintain bone matrix integrity and remain
in good condition to be transplanted later. However, it is a
quite complex and expensive method.3,6-10
The purpose of performing a study involving an alter-
native method of bone graft preservation was to make avail-
able a method as effective as cryopreservation, although
much less expensive, since this would allow for storage of
the allografts at room temperature and facilitate their trans-
portation to the surgical site.
Various reports describe the use of highly concentrated
glycerol solutions as an alternative medium for preserving
homologous tissues stored at room temperature. It has been
claimed that such methodology does not alter the fundamen-
tal features of tissues, maintaining the architecture of the
graft for at least 1 year. Moreover, glycerol has bactericidal
and fungicidal properties and inhibits the onset of an im-
mune response to foreign matter. However, the literature con-
cerning orthopedics does not refer to preservation of osteo-
fascial-chondral-ligamentous tissues with this agent. 5,11-16.
The objective of this study was to test a 98% glycerol
solution for antibacterial and antifungal effects when bone
tissues are kept at room temperature (10ºC -35ºC). A com-
parative analisys of histological changes resulting from
cryopreservation versus 98% glycerol solution was also
underrtaken.
METHOD
This study used 30 samples of trabecular bone tissue
from 10 patients undergoing total hip arthroplasty (THA)
performed by the Hip Group of the Institute of Orthoped-
ics and Traumatology, Hospital das Clínicas, Faculty of
Medicine of the University of Sao Paulo, Brazil. The femo-
ral heads were included in this research project after the
patients gave their explicit informed consent. The samples
were identified by numbers in ascending order according
to surgery dates.
Samples were collected in a surgery room of the Insti-
tute’s Tissue Bank provided with vertical laminar flow and
Class 100 absolute HEPA (high efficiency particulate air)
filters. Rigorous aseptic technique was used throughout
every procedure.
Of the 30 samples, 10 formed the control group; 10
were subjected to cryopreservation (at -80ºC), while another
10 were preserved in 98% glycerol solution for 1 year.
The histological and microbiological investigation were
performed at 2 different time points: immediately after the
sample processing and after 1 year. Aerobic and anaerobic
bacterial cultures, as well as fungal cultures, were per-
formed. Because the method has already been established
and used in many centers, we chose not to microbiologi-
cally analyze the cryopreserved samples.
All samples were submitted to histomorphologic and
cell feasibility analysis. Microscopy was used to analyze
the amount of osteoblasts, osteoclasts, osteocytes, and
fibroblasts, as well as the presence of immature and lamel-
lar bone, nonmineralized osteoid, and necrosis. This analy-
sis allowed us to evaluate cell feasibility and bone matrix
maintenance. For tissue analysis, we established the fol-
lowing scores: absent (#), reduced (+), normal (++), and
increased (+++) (Table 1); for the cell feasibility analysis,
the scores were absent (#) and normal (+) (Table 2).
The statistical analysis considered that the experimental
units were 10 subjects, each one of them providing 3 bone
slices (observation units) that were individually subjected to
a different experimental condition. So, the study followed a
plan in which bone slices of the same individual were observed
under 3 different experimental conditions, generating 3 sam-
ples that may be not independent. For each given bone slice
from and individual that was observed in the control group,
Table 1 - Histomorphologic description of samples
HISTOMORPHOLOGY
SAMPLE # CONTROL (Gc) CRYOPRESERVED (Gcryo12) GLYCEROL 98% (Gg12)
MB IB OST NEC MB IB OST NEC MB IB OST NEC
1 ++ # # +++ ++ # # +++ ++ # # +++
2 ++ + # # ++ # # +++ ++ # # +++
3 ++ # # # ++ # # +++ ++ # # +++
4 ++ # # # ++ +++ # +++ ++ +++ # +++
5 ++ +++ # +++ ++ +++ # +++ ++ +++ # +++
6 +++ +++ # # +++ +++ # # +++ +++ # #
7 +++ # # # +++ # # # +++ # # #
8 ++ +++ # +++ ++ +++ # +++ ++ +++ # +++
9 ++ # # # ++ # # +++ ++ # # +++
10 ++ +++ # +++ +++ +++ # +++ ++ ++ # +++
SCORE: # : absent; + : reduced; ++ : normal; +++ : increased; MB: mature or lamellar bone; IB: immature bone; OST: nonmineralized osteoid; NEC:
necrosis
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corresponding slices will exist in the cryopreserved and glyc-
erol groups, so that we had paired samples.
Initially, we developed tables including frequency dis-
tributions and percentages of the morphology and cell fea-
sibility variables under each of the experimental conditions
(control, cryopreservation, and glycerol). These conditions
were compared in terms of probability of occurrence of the
category of each variable. These comparisons were made
using paired conditions (control versus cryopreservation,
control versus glycerol, and cryopreservation versus glyc-
erol), using the McNemar test (Fisher and van Belle, 1993).
This technique takes into account the pairing adopted to
conduct the study. Since the sample size was small, the pre-
cise distribution of the test statistics was considered. The
global significance level of the comparison of each vari-
able under each of the 3 experimental conditions was es-
tablished as 0.05.
RESULTS
The microbiologic analysis of the 98% glycerol solu-
tion and bone fragments from samples stored for 1 year at
room temperature did not show bacterial or fungal growth.
Histomorphologic description of samples and cell fea-
sibility data are presented in Tables 1 and 2. We did not
test the nonmineralized osteoid variable because the val-
ues assumed by this variable did not vary (the category was
observed in all slices). The descriptive levels indicated that
there were no differences between the distributions of the
following variables: mature bone, immature bone, and
necrosis under the 3 experimental conditions.
We did not perform hypothesis tests for the cell feasi-
bility variables, osteocytes and fibroblasts, since their re-
sults did not vary, with all slices falling in a normal cat-
egory. Also, we did not compare distribution of osteoblasts
in the controls versus the cryopreserved and glycerol groups
because the control group presented normal results in all
samples. The results of the statistical analysis indicated that
there was no difference between the distributions of the
variables, osteoblasts and osteoclasts, under the two stor-
age conditions. The frequency distributions, percentages of
the variables, and results of hypothesis testing under the 3
experimental conditions are shown in Tables 3, 4, and 5.
The absolute and relative frequencies of the scores in
mature or lamellar bone are presented in Table 3.
The P values obtained by the MacNemar test for
histomorphometric variables are shown in Table 4. Con-
cerning the immature bone (IB) variable, the reduced, nor-
mal, and increased categories were grouped into a single
category so that the test could be applied. The probability
levels (P) indicate that there were no differences between
the distributions of the mature bone (MB), immature bone
(IB) and necrosis (NEC) variables under the 3 experimen-
tal conditions.
As previously mentioned, the cell feasibility analysis
did not include hypothesis testing for osteocytes (OSTs) and
fibroblasts (FBs) because for these two variables the nor-
mal category was observed in all slices under the 3 experi-
mental conditions. The probability levels achieved in the
analysis of these two variables are shown in Table 5. Our
conclusion was that the control, cryopreservation, and glyc-
erol groups did not differ in terms of distribution of
osteoblasts (OBs) and osteoclasts (OCs); the probabilities
Table 2 - Cell feasibility description of samples
SAMPLE # CONTROL (Gc) CRYOPRESERVED (Gcryo12 98% GLYCEROL SOLUTION
(Gg12)
 OB OC OST FB OB OC OST FB OB OC OST FB
1 + + + + # # + + # # + +
2 + + + + + # + + + # + +
3 + + + + + # + + + # + +
4 + + + + + # + + + # + +
5 + + + + + + + + + + + +
6 + + + + + + + + + # + +
7 + + + + + + + + + + + +
8 + + + + + + + + + # + +
9 + + + + + + + + + + + +
10 + + + + + + + + + + + +
SCORE: # : absent; + : normal; OB: osteoblasts; OC: osteoclasts; OST: osteocytes; FB: fibroblast; Gc: control group; Gg12: 98% glycerol solution
group; Gcryo12: cryopreserved group
Table 3 - Absolute and relative frequencies of the scores in
mature or lamellar bone
Group
Control Cryopreserved 98% glycerol
Score n % n % n %
Normal 8 80.0 7 70.0 8 80.0
Increased 2 20.0 3 30.0 2 20.0
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of occurrence of the absent or normal categories of OBs
and OCs are equal under the 3 experimental conditions.
DISCUSSION
In orthopedics and dentistry, interest in development of
techniques to compensate for bone loss increases every day.
Therefore, allografts have been chosen as the main source
of bone tissue supply and have become an alternative to
the use of autologous grafts.
The first step in obtaining allografts consists of a rig-
orous selection of the donor. After the screening of donors,
the next step is tissue removal using suitable surgical tech-
nique and processing, followed by the final storage stage.
Currently, the most frequently used preservation method
for bone tissues is cryopreservation, that is, the use of low
temperatures (minimum –80º C). The use of this method
involves high costs because, apart from the intrinsic value
of the freezing units, indirect costs such as preventive main-
tenance, maintenance of a properly refrigerated room, 24-
hour/day alarm systems, and power generators in case of
lack of power must also be considered.
Glycerol at high concentrations is known to have anti-
bacterial, antifungal, and antiviral action. Several studies
have shown that a 98% solution of glycerol at room tem-
perature is effective in preserving biological tissues.11,18-23
However, there are no studies in the orthopedic litera-
ture regarding preservation and storage of osteofascial-
chondral-ligamentous tissues with this agent. Only Pigossi
(1964) and Backere (1994) have suggested the use of this
method to preserve bones.
In order to ensure that the process of allograft bone in-
tegration will effectively occur, the status of bone matrix
preservation is fundamental. In both preservation methods
examined in this study, this matrix was kept preserved, and
no statistically significant changes were found. This im-
portant aspect is related to the preservation method, since
the bone matrix (not the cell feasibility) is a desirable item
in bone allograft.24
Another essential aspect of bone preservation for
allografts is the absence of growth of bacteria and fungi in
the preserved samples. The results with glycerol preserva-
tion/room-temperature storage are similar to those obtained
with the cryopreservation method at – 80°C. However, fur-
ther studies must be performed to evaluate other items such
as:
? Maintenance of the bone matrix osteoinductive ca-
pacity;
? Cell-mediated immune response to the allograft, be-
cause the preserved cells may retain recognizable
alloantigens;
? Biomechanical properties, which play an important
role in the therapeutic success of transplants. It is
fundamental that the preservation method used does
not compromise the rigidity of allografts and the
forces acting on them.
? Removal of glycerol from the bone tissue and meas-
urement of the quantity retained in the graft, in or-
der to determine the levels of tolerance of this tri-
alcohol.
CONCLUSIONS
1) There was no bacterial or fungal growth in samples
stored for 1 year in a 98% glycerin solution at room
temperature (10 ºC -35ºC).
2) Both preservation methods were similar in terms of
bone matrix preservation.
Table 5 - P values for the McNemar test in the comparison of probability distributions of cell feasibility variables under 3
experimental conditions
Variable Control versus Cryopreserved Control versus Glycerol Cryopreserved versus Glycerol
OB > 0.999 > 0.999 > 0.999
OC 0.188 0.096 0.500
OB = osteoblasts; OC = osteoclasts
Table 4 - P values for the McNemar test in the comparison of probability distributions of histomorphologic variables
under 3 experimental conditions
Variable Control versus Cryopreserved Control versus Glycerol Cryopreserved versus Glycerol
MB > 0.999 > 0.999 > 0.999
IB > 0.999 > 0.999 > 0.999
NEC 0.375 0.375 > 0.999
MB = mature or lamellar bone; IB = immature bone; NEC = necrosis
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RESUMO
Giovani AMM, Croci AT, Oliveira CRGCM, Filippi RZ,
Santos LAU, Maragni GG. Estudo comparativo entre o
tecido ósseo criopreservado e o conservado em glicerol a
98%. Clinics. 2006;61(6):565-70.
OBJETIVO: Comparar o método da criopreservação de
enxertos ósseos (– 80° C) com o da conservação em glicerol
a 98% em temperatura ambiente (10º C a 35º C), testando
os efeitos antibacterianos e antifúngicos do glicerol a 98%
e analisando comparativamente as alterações histológicas
verificadas e decorrentes do emprego dos dois métodos.
MÉTODO: Este estudo foi constituído de 30 amostras de
tecido ósseo trabecular provenientes de 10 pacientes,
submetidos a Artroplastia Total do Quadril. Cada cabeça femo-
ral forneceu 3 amostras e estas foram divididas aleatoriamente
em 3 grupos, a saber: controle, criopreservado e conservado
em glicerol a 98% à temperatura ambiente durante um ano.
As amostras foram encaminhadas à Anatomia Patológica para
estudo histomorfologico, de viabilidade celular, e micro-
biológico. Os resultados foram analisados estatisticamente pelo
método de McNemar, com índice de significância de 0,05.
RESULTADOS: A análise dos valores obtidos no teste de
McNemar na comparação das distribuições de
probabilidades das variáveis da histomorfologia (osso
maduro ou lamelar, osso imaturo e necrose) e da viabilidade
celular (osteoblastos e osteoclastos) indica não haver
diferença entre as distribuições das variáveis nas três
condições experimentais. A análise microbiológica da
solução de glicerol a 98% e dos fragmentos ósseos das
amostras armazenadas durante um ano em temperatura
ambiente não apresentou crescimento bacteriano ou de
fungos. As espécimens do grupo controle foram analisadas
histológica e microbiologicamente logo após a coleta das
mesmas.
CONCLUSÃO: O método de conservação de enxertos
ósseos mantidos no glicerol a 98% em temperatura
ambiente (10ºC a 35ºC) foi similar ao da criopreservação
quanto à preservação da matriz óssea e à ausência de
crescimento de bactérias ou fungos.
UNITERMOS: Tecido ósseo. Glicerol. Transplante ósseo.
Criopreservação. Enxerto ósseo.
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